| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Toxoplasma | 17 | 2021 | 116 | 3.200 |
Why?
|
| Toxoplasmosis | 11 | 2021 | 66 | 2.640 |
Why?
|
| Plasmodium falciparum | 12 | 2020 | 48 | 1.650 |
Why?
|
| Protozoan Vaccines | 3 | 2019 | 11 | 1.130 |
Why?
|
| Protozoan Proteins | 9 | 2018 | 74 | 1.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2020 | 624 | 0.960 |
Why?
|
| Vaccines, Subunit | 3 | 2020 | 55 | 0.820 |
Why?
|
| Antigens, Protozoan | 3 | 2020 | 21 | 0.740 |
Why?
|
| Antimalarials | 3 | 2019 | 20 | 0.720 |
Why?
|
| Epitopes | 1 | 2020 | 249 | 0.670 |
Why?
|
| Protozoan Infections | 1 | 2019 | 3 | 0.650 |
Why?
|
| Toxoplasmosis, Congenital | 2 | 2021 | 49 | 0.640 |
Why?
|
| Spermine | 1 | 2019 | 25 | 0.620 |
Why?
|
| Spermidine | 1 | 2019 | 13 | 0.620 |
Why?
|
| Polyamines | 1 | 2019 | 38 | 0.610 |
Why?
|
| Membrane Transport Proteins | 3 | 2010 | 171 | 0.580 |
Why?
|
| Purines | 3 | 2010 | 97 | 0.560 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2020 | 461 | 0.550 |
Why?
|
| Nanoparticles | 2 | 2020 | 168 | 0.550 |
Why?
|
| Centrosome | 1 | 2016 | 22 | 0.510 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2016 | 22 | 0.500 |
Why?
|
| Cell Division | 1 | 2016 | 701 | 0.450 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 389 | 0.430 |
Why?
|
| HLA-B7 Antigen | 3 | 2020 | 7 | 0.380 |
Why?
|
| Immunoglobulin G | 5 | 2021 | 460 | 0.380 |
Why?
|
| Antiprotozoal Agents | 3 | 2019 | 33 | 0.360 |
Why?
|
| Photosynthetic Reaction Center Complex Proteins | 2 | 2001 | 27 | 0.350 |
Why?
|
| Antibodies, Protozoan | 3 | 2021 | 42 | 0.340 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 1589 | 0.330 |
Why?
|
| Cyanobacteria | 2 | 2001 | 114 | 0.330 |
Why?
|
| Point-of-Care Testing | 2 | 2021 | 21 | 0.330 |
Why?
|
| Epitopes, T-Lymphocyte | 3 | 2016 | 89 | 0.320 |
Why?
|
| Malaria | 2 | 2019 | 23 | 0.320 |
Why?
|
| Morocco | 4 | 2024 | 17 | 0.300 |
Why?
|
| Biological Transport | 1 | 2008 | 410 | 0.280 |
Why?
|
| Erythrocytes | 5 | 2010 | 251 | 0.280 |
Why?
|
| Animals | 19 | 2020 | 28003 | 0.260 |
Why?
|
| Immunoglobulin M | 4 | 2021 | 161 | 0.260 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 1 | 2024 | 11 | 0.230 |
Why?
|
| Mice | 8 | 2020 | 12110 | 0.220 |
Why?
|
| Toxoplasmosis, Animal | 2 | 2015 | 20 | 0.210 |
Why?
|
| Cell Membrane | 1 | 2006 | 684 | 0.210 |
Why?
|
| Gene Deletion | 3 | 2016 | 351 | 0.200 |
Why?
|
| Inhibitory Concentration 50 | 3 | 2019 | 66 | 0.200 |
Why?
|
| Light | 2 | 2001 | 295 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 3360 | 0.190 |
Why?
|
| Methyltransferases | 3 | 2008 | 198 | 0.190 |
Why?
|
| Parasitic Sensitivity Tests | 2 | 2019 | 5 | 0.180 |
Why?
|
| Adjuvants, Immunologic | 2 | 2020 | 169 | 0.180 |
Why?
|
| Photosystem I Protein Complex | 1 | 2001 | 11 | 0.180 |
Why?
|
| Host-Parasite Interactions | 2 | 2019 | 30 | 0.180 |
Why?
|
| Immunoassay | 2 | 2021 | 93 | 0.180 |
Why?
|
| Parasitemia | 2 | 2019 | 6 | 0.180 |
Why?
|
| HLA-A11 Antigen | 1 | 2020 | 2 | 0.180 |
Why?
|
| Interferon-gamma | 2 | 2014 | 453 | 0.180 |
Why?
|
| HLA-A2 Antigen | 1 | 2020 | 30 | 0.180 |
Why?
|
| Peptides | 3 | 2014 | 656 | 0.170 |
Why?
|
| Parasites | 1 | 2020 | 9 | 0.170 |
Why?
|
| Cells, Cultured | 4 | 2020 | 2902 | 0.170 |
Why?
|
| Trypanosomiasis | 1 | 2019 | 1 | 0.160 |
Why?
|
| Trypanosoma | 1 | 2019 | 3 | 0.160 |
Why?
|
| Plasmodium | 1 | 2019 | 10 | 0.160 |
Why?
|
| Protein Engineering | 1 | 2020 | 146 | 0.160 |
Why?
|
| Gene Expression Regulation, Bacterial | 1 | 2001 | 219 | 0.160 |
Why?
|
| Parasite Load | 1 | 2019 | 2 | 0.160 |
Why?
|
| Plasmodium yoelii | 1 | 2019 | 4 | 0.160 |
Why?
|
| Colombia | 1 | 2018 | 17 | 0.150 |
Why?
|
| France | 1 | 2018 | 51 | 0.150 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2018 | 16 | 0.150 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 1919 | 0.150 |
Why?
|
| Serologic Tests | 1 | 2018 | 43 | 0.150 |
Why?
|
| Enzymes | 1 | 2018 | 46 | 0.150 |
Why?
|
| Drug Synergism | 1 | 2019 | 312 | 0.150 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 2448 | 0.150 |
Why?
|
| Genetic Complementation Test | 2 | 2016 | 98 | 0.140 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 786 | 0.140 |
Why?
|
| Public Health | 1 | 2018 | 145 | 0.140 |
Why?
|
| HLA-A Antigens | 1 | 2016 | 40 | 0.130 |
Why?
|
| Candida | 1 | 2006 | 18 | 0.130 |
Why?
|
| Cross-Priming | 1 | 2016 | 49 | 0.130 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 1163 | 0.130 |
Why?
|
| Models, Molecular | 3 | 2018 | 1336 | 0.130 |
Why?
|
| Humans | 17 | 2024 | 92337 | 0.130 |
Why?
|
| Quinolones | 1 | 2016 | 57 | 0.130 |
Why?
|
| Amino Acids | 1 | 2006 | 255 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 2394 | 0.120 |
Why?
|
| Drug Discovery | 1 | 2016 | 110 | 0.120 |
Why?
|
| Bacterial Translocation | 1 | 2015 | 26 | 0.120 |
Why?
|
| Salmonella Infections, Animal | 1 | 2015 | 11 | 0.120 |
Why?
|
| Immunologic Memory | 1 | 2016 | 177 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 39 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2016 | 159 | 0.120 |
Why?
|
| Salmonella typhimurium | 1 | 2015 | 32 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 1108 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 108 | 0.110 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 252 | 0.110 |
Why?
|
| Triclosan | 1 | 2013 | 10 | 0.110 |
Why?
|
| Enoyl-(Acyl-Carrier-Protein) Reductase (NADH) | 1 | 2013 | 12 | 0.110 |
Why?
|
| United States | 4 | 2018 | 7348 | 0.100 |
Why?
|
| Spleen | 1 | 2014 | 435 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2015 | 476 | 0.100 |
Why?
|
| Morpholinos | 1 | 2012 | 13 | 0.100 |
Why?
|
| Gene Expression Profiling | 2 | 2016 | 1477 | 0.100 |
Why?
|
| Culture Media | 2 | 2006 | 149 | 0.100 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2012 | 51 | 0.090 |
Why?
|
| Female | 9 | 2024 | 47893 | 0.090 |
Why?
|
| Phosphatidylcholines | 2 | 2008 | 50 | 0.090 |
Why?
|
| Benzamides | 1 | 2012 | 239 | 0.090 |
Why?
|
| Phycobilisomes | 2 | 2001 | 8 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2015 | 702 | 0.090 |
Why?
|
| Ribosomal Proteins | 1 | 2010 | 45 | 0.090 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 2009 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 968 | 0.090 |
Why?
|
| Nucleoside Transport Proteins | 1 | 2010 | 3 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 652 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 814 | 0.080 |
Why?
|
| Tubulin | 1 | 2010 | 60 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2012 | 379 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2001 | 402 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2010 | 515 | 0.080 |
Why?
|
| Xanthine | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cytoskeleton | 1 | 2010 | 202 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 259 | 0.070 |
Why?
|
| Guanosine | 1 | 2008 | 30 | 0.070 |
Why?
|
| Adenine | 1 | 2008 | 89 | 0.070 |
Why?
|
| Boron Compounds | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1720 | 0.070 |
Why?
|
| Proteasome Inhibitors | 1 | 2007 | 52 | 0.070 |
Why?
|
| Boronic Acids | 1 | 2007 | 54 | 0.070 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 72 | 0.070 |
Why?
|
| Guanine | 1 | 2008 | 207 | 0.070 |
Why?
|
| Case-Control Studies | 2 | 2024 | 1902 | 0.070 |
Why?
|
| Pyrazines | 1 | 2007 | 92 | 0.070 |
Why?
|
| HIV Infections | 1 | 2016 | 895 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 403 | 0.070 |
Why?
|
| Oligopeptides | 1 | 2007 | 190 | 0.060 |
Why?
|
| Gene Targeting | 1 | 2006 | 74 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 184 | 0.060 |
Why?
|
| Golgi Apparatus | 1 | 2006 | 117 | 0.060 |
Why?
|
| Prevalence | 2 | 2021 | 1294 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2021 | 891 | 0.060 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 250 | 0.060 |
Why?
|
| Permeability | 2 | 2015 | 141 | 0.060 |
Why?
|
| Methylation | 3 | 2010 | 280 | 0.050 |
Why?
|
| Pregnancy | 2 | 2021 | 3110 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2011 | 2074 | 0.050 |
Why?
|
| Drug Resistance | 2 | 2016 | 235 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 55 | 0.050 |
Why?
|
| Diuron | 1 | 2001 | 4 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2012 | 2037 | 0.050 |
Why?
|
| Photosystem II Protein Complex | 1 | 2001 | 22 | 0.050 |
Why?
|
| Lighting | 1 | 2001 | 33 | 0.050 |
Why?
|
| Electron Transport | 1 | 2001 | 75 | 0.050 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2021 | 38 | 0.040 |
Why?
|
| Laboratories | 1 | 2021 | 44 | 0.040 |
Why?
|
| Adult | 4 | 2024 | 27532 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 77 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2021 | 86 | 0.040 |
Why?
|
| Thylakoids | 1 | 2000 | 10 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2021 | 77 | 0.040 |
Why?
|
| Fluorescence | 1 | 2000 | 104 | 0.040 |
Why?
|
| Genotype | 1 | 2024 | 1863 | 0.040 |
Why?
|
| Phenotype | 1 | 2006 | 2498 | 0.040 |
Why?
|
| Aged | 3 | 2024 | 19943 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 302 | 0.040 |
Why?
|
| Malaria, Falciparum | 2 | 2010 | 12 | 0.040 |
Why?
|
| Fibroblasts | 2 | 2012 | 767 | 0.040 |
Why?
|
| Radiography, Thoracic | 1 | 2021 | 332 | 0.040 |
Why?
|
| Temperature | 1 | 2000 | 404 | 0.040 |
Why?
|
| Abortion, Spontaneous | 1 | 2018 | 67 | 0.040 |
Why?
|
| Time Factors | 2 | 2018 | 5430 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2024 | 1392 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 27030 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 147 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2018 | 507 | 0.030 |
Why?
|
| Serine | 2 | 2008 | 105 | 0.030 |
Why?
|
| Hyphae | 1 | 2006 | 7 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 6624 | 0.030 |
Why?
|
| Developing Countries | 1 | 2017 | 83 | 0.030 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2017 | 64 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 154 | 0.030 |
Why?
|
| Parasite Egg Count | 1 | 2016 | 6 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2016 | 9 | 0.030 |
Why?
|
| Oocysts | 1 | 2016 | 7 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1939 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 2368 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 9504 | 0.030 |
Why?
|
| Microscopy | 1 | 2006 | 88 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 2447 | 0.030 |
Why?
|
| Cats | 1 | 2016 | 305 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2016 | 71 | 0.030 |
Why?
|
| Morbidity | 1 | 2016 | 157 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2018 | 902 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2010 | 455 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 2015 | 16 | 0.030 |
Why?
|
| Occludin | 1 | 2015 | 66 | 0.030 |
Why?
|
| Morphogenesis | 1 | 2006 | 207 | 0.030 |
Why?
|
| Transplantation Chimera | 1 | 2015 | 84 | 0.030 |
Why?
|
| Feces | 1 | 2016 | 349 | 0.030 |
Why?
|
| Virulence | 1 | 2015 | 277 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2015 | 289 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 123 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2015 | 473 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 239 | 0.030 |
Why?
|
| Apicomplexa | 1 | 2012 | 5 | 0.030 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2012 | 34 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 307 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 987 | 0.020 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2012 | 8 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 432 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 129 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2012 | 142 | 0.020 |
Why?
|
| Secretory Pathway | 1 | 2012 | 22 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2012 | 152 | 0.020 |
Why?
|
| Incidence | 1 | 2016 | 1661 | 0.020 |
Why?
|
| Organelles | 1 | 2012 | 57 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2015 | 438 | 0.020 |
Why?
|
| Male | 3 | 2024 | 43925 | 0.020 |
Why?
|
| Tetracyclines | 1 | 2010 | 5 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 5704 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2680 | 0.020 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 139 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 373 | 0.020 |
Why?
|
| Floxuridine | 1 | 2010 | 10 | 0.020 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2010 | 29 | 0.020 |
Why?
|
| Immunization | 1 | 2010 | 163 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 430 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 383 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2010 | 323 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 27 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 2087 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 79 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 183 | 0.020 |
Why?
|
| RNA, Catalytic | 1 | 2010 | 134 | 0.020 |
Why?
|
| Acetylation | 1 | 2010 | 146 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2010 | 276 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 3218 | 0.020 |
Why?
|
| Vaccination | 1 | 2011 | 285 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 795 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2016 | 3818 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2010 | 358 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 283 | 0.020 |
Why?
|
| Ethanolamine | 1 | 2008 | 2 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 901 | 0.020 |
Why?
|
| Ethanolamines | 1 | 2008 | 25 | 0.020 |
Why?
|
| Life Cycle Stages | 1 | 2007 | 15 | 0.020 |
Why?
|
| Proteomics | 1 | 2010 | 246 | 0.020 |
Why?
|
| S-Adenosylmethionine | 1 | 2008 | 27 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2008 | 119 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2010 | 465 | 0.020 |
Why?
|
| Bortezomib | 1 | 2007 | 81 | 0.020 |
Why?
|
| Catalysis | 1 | 2008 | 210 | 0.020 |
Why?
|
| DNA Replication | 1 | 2007 | 173 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1513 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2008 | 336 | 0.020 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2006 | 2 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2006 | 29 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2012 | 907 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2008 | 288 | 0.020 |
Why?
|
| Transgenes | 1 | 2006 | 184 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2010 | 967 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3017 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2011 | 1277 | 0.010 |
Why?
|
| Child | 1 | 2016 | 7334 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2010 | 1240 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 1684 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 2004 | 0.010 |
Why?
|
| Brain | 1 | 2010 | 2352 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2010 | 3508 | 0.010 |
Why?
|